Titan Pharmaceuticals
TTNP
$6.88
Share price
-2.55%
Change (1 day)
805.26%
Change (1 year)
Categories
Titan Pharmaceuticals (TTNP) - Cash on Hand
Cash on Hand as of December 2023 : $6.76 M
According to Titan Pharmaceuticals
's latest financial reports the company has $6.76 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Titan Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $2.93 M | -51.35% |
| 2021-12-31 | $6.03 M | 11.53% |
| 2020-12-31 | $5.41 M | 3.64% |
| 2019-12-31 | $5.22 M | -43.81% |
| 2018-12-31 | $9.29 M | 23.57% |
| 2017-12-31 | $7.52 M | -46.29% |
| 2016-12-31 | $14 M | 78.26% |
| 2015-12-31 | $7.85 M | -49.21% |
| 2014-12-31 | $15.47 M | 31.12% |
| 2013-12-31 | $11.79 M | -34.82% |
| 2012-12-31 | $18.1 M | 234.85% |
| 2011-12-31 | $5.4 M | 70% |
| 2010-12-31 | $3.18 M | -3.64% |
| 2009-12-31 | $3.3 M | |
| 2007-12-31 | $30.01 M | 118.86% |
| 2006-12-31 | $13.71 M | -21.04% |
| 2005-12-31 | $17.36 M | -52.18% |
| 2004-12-31 | $36.32 M | -21.98% |
| 2003-12-31 | $46.55 M | -36.62% |
| 2002-12-31 | $73.45 M | -30.08% |
| 2001-12-31 | $0.10 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 339,056.80% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 143,302.37% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | $0.38 B | 5,643.55% | 🇺🇸 USA |
 Repligen
RGEN | $0.75 B | 11,014.25% | 🇺🇸 USA |
 MediciNova MNOV | $50.99 M | 654.43% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | 6,166.24% | 🇺🇸 USA |